Amanote Research

Amanote Research

    RegisterSign In

ATM-Deficient Cancers Provide New Opportunities for Precision Oncology

Cancers - Switzerland
doi 10.3390/cancers12030687
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

March 14, 2020

Authors
Nicholas R. JetteMehul KumarSuraj RadhamaniGreydon ArthurSiddhartha GoutamSteven YipMichael KolinskyGareth J. WilliamsPinaki BoseSusan P. Lees-Miller
Publisher

MDPI AG


Related search

Editorial: Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers

Frontiers in Oncology
Cancer ResearchOncology
2020English

Translating Cancer Genomes and Transcriptomes for Precision Oncology

CA - A Cancer Journal for Clinicians
OncologyHematology
2015English

Precision Oncology: East Meets West

International Journal of Cancer
Cancer ResearchOncology
2018English

Precision Oncology in Urothelial Cancer

ESMO Open
Cancer ResearchOncology
2020English

Emerging Opportunities for Target Discovery in Rare Cancers

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2017English

Opportunities for Artificial Intelligence in Advancing Precision Medicine

Current Genetic Medicine Reports
2019English

Master Regulators May Be Therapeutic Targets for Precision Oncology

Cancer Discovery
Oncology
2018English

Precision Radiation Oncology: Achievements and Challenges

Precision Radiation Oncology
2017English

Recent Advances in Precision Oncology Research

npj Precision Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy